Download PDF

Other users also viewed these articles

Reply to: “Vasopressin: Why not in severe traumatic disease?” Juan Carlos Ruíz-Rodríguez, Ana Ochagavia, Lluís Zapata, Ricard Ferrer
10.1016/j.medine.2025.502220
Ten take-home messages on vasopressin use in critically ill patients Ricard Ferrer, Pedro Castro, Carol Lorencio, Josman Monclou, Pilar Marcos, Ana Ochagavia, Juan Carlos Ruíz-Rodríguez, Josep Trenado, Christian Villavicencio, Juan Carlos Yébenes, Lluís Zapata
10.1016/j.medine.2024.09.009
Severe traumatic disease register in Spain M. Chico-Fernández, J.A. Llompart-Pou, M. Sánchez-Casado, M.Á. Ballesteros-Sanz
10.1016/j.medine.2017.02.014